Are you living with Idiopathic Pulmonary Fibrosis (IPF)? You may have the opportunity to be considered for a new Phase I clinical research study evaluating an investigational treatment for IPF.

If you are interested in learning more about this study and whether you may qualify, please contact our research team to learn more about participation, eligibility requirements, and what to expect.

Are you living with Type 1 Diabetes? You may have the opportunity to participate in a Phase II clinical study evaluating a non-surgical insulin delivery device.

The study involves a co-formulated insulin product containing long-acting basal insulin and rapid-acting insulin. The study is designed to evaluate the treatment over several phases:

Screening & Lead-In: Approximately 2 weeks

Treatment Period: 16 weeks

Safety Follow-Up: 2 weeks

If you are interested in learning more about this study and whether you may qualify, contact our research team to learn more about participation and eligibility requirements.

Are you 18 years or older and living with moderately to severely active Ulcerative Colitis (UC)? If you have not responded adequately to previous treatment, you may be eligible to join our Phase II clinical research study.

The study includes a 10-week induction period, followed by a 40-week active treatment period and an approximately 1-year long-term extension.

If you are interested in participating and want to learn more about eligibility, please contact our research team today.

Are you 18 years or older and living with moderate to severe Crohn’s Disease? If you have had an inadequate response to previous treatment, you may be eligible to participate in our Phase II clinical research study.

The study includes a 10-week induction period, followed by a 40-week active maintenance period and an approximately 1-year long-term extension period.

If you are interested in participating and would like to learn more about eligibility and what to expect, please contact our research team today.

Are you living with non-small cell lung cancer (NSCLC) with a KRAS G12D mutation? You may be eligible to participate in a Phase III clinical research study evaluating an investigational treatment compared with docetaxel.

This study is for participants with locally advanced (unresectable) or metastatic NSCLC whose cancer has progressed during or after treatment with platinum-based chemotherapy and checkpoint inhibitor therapy.

If you are interested in learning more about this study and whether you may qualify, please contact our research team today.

Are you living with moderately to severely active Ulcerative Colitis (UC) and have previous treatments not worked well enough for you? You may be eligible to participate in a Phase II/III clinical research study evaluating a novel oral treatment with a new mechanism of action.

This study is evaluating the safety and effectiveness of the investigational study drug in people with moderately to severely active UC who have had an inadequate response to or failed previous conventional or advanced UC therapies.

If you are interested in participating and would like to learn more about eligibility and what the study involves, contact our research team today.

Are you living with Dermatomyositis (DM) or Polymyositis (PM)? You may be eligible to participate in a Phase II/III clinical research study evaluating an investigational treatment made from umbilical cord-lining stem cells.

This study is designed to evaluate the safety and effectiveness of allogeneic ULSC and its potential to improve disease severity and help participants reduce their reliance on steroid treatment.

If you are interested in participating and would like to learn more about eligibility and what the study involves, contact our research team today.

Living With Pulmonary Hypertension and Heart Failure?

If you are an adult with obesity, pulmonary hypertension, and heart failure with preserved ejection fraction (PH-HFpEF), you may be eligible to participate in an early-phase clinical research study.

This Phase 1b study is evaluating an investigational treatment to learn more about its safety, effectiveness, and how it affects pulmonary artery pressure and heart function.

Interested in participating? Learn more and see if you may qualify.

Experiencing Pain or Burning When You Urinate?

If you are a woman experiencing pain or burning when urinating due to an uncomplicated urinary tract infection (UTI), you may be eligible to participate in a clinical research study.

This study is evaluating an investigational over-the-counter (OTC) pain reliever to determine its safety and effectiveness in providing short-term relief from UTI-related pain and burning.

Interested in participating? Learn more and see if you may qualify.